Hutch News
Results per Page:
New Scientific Publications
Each week, Fred Hutch librarians search PubMed and Web of Science to discover new papers published by Fred Hutch authors
Week of December 01, 2019
Galloway and Hartwell to enter Washington Life Science Hall of Fame
Awards recognize power of basic research, leadership in driving advances for patients
High-Risk HPV Impairs the Homologous Recombination Pathway
From the Galloway Lab, Human Biology Division
HPV and cancer: Risks for non-HPV16 and HPV18 strains
From the Galloway and Hughes Labs (Human Biology and Vaccine and Infectious Disease Divisions)
Good News: Global Oncology wins NCI grant; 1100 Eastlake building honored; Bish Paul essay in Science; Dr. Joseph Unger leads finasteride study
Celebrating faculty and staff achievements
Forgotten patients: New guidelines help those with head-and-neck cancers
Stigma, isolation and medical complexity may keep patients from getting all the care they need; recommendations aim to change that
‘It’s been an incredible ride’
Dr. Denise Galloway reflects on a career — and a life — touched by cancer
More early cervical cancer cases being detected under Affordable Care Act
New study finds higher rates of young women covered by parents' private insurance being diagnosed, treated earlier
Seahawk Earl Thomas’ parents visit Fred Hutch
Debbie Thomas, cervical cancer survivor, met Dr. Denise Galloway and discussed HPV vaccine
HPV vaccines work – so why do so few states require them?
Only Virginia, Washington, D.C., and soon, Rhode Island, include the cancer-preventing vaccine as a school requirement
HPV vaccinations save men’s lives, too
Study finds higher HPV immunization rates among women block cancers in men
HPV vaccine: It’s not about sex, it’s about cancer
New, large study shows HPV vaccine does not increase sexual behavior in teen girls
Should HPV test replace the Pap for cervical cancer screening?
A panel of experts offers interim guidance – but main message is get screened and vaccinated
1 in 10 women is not being screened for cervical cancer
As with the HPV vaccine, a key barrier is 'missed opportunities' among doctors
The HPV cancer vaccine: Are two doses as good as three?
A reduced dosing regimen may increase vaccination adherence, decrease costs
A missed opportunity to prevent cancer
Presidential panel calls for boost in lagging HPV vaccination rates among U.S. adolescents